Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

Doctors have found that Covid-19's inflammation can cause long-term cardiovascular issues, such as accelerated plaque buildup ...

Utilising Machine Learning on clinical datasets could help to crack the enigma of feline infectious peritonitis diagnosis ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...

The global prevalence of COVID-flu coinfection is 14%, with Asia and Europe having the highest rates of influenza A/B ...